Panjon schedules AGM to regularize Archit Kothari, re-appoint Anju Kothari
- Panjon schedules 43rd AGM for September 30, 2026, to adopt FY26 results
- Revenue surged 56.35% YoY to ₹476.2 crore; net profit rose 20.23% to ₹47.6 crore
- Agenda includes regularizing Mr. Archit Kothari as a Non-Executive Director
- Secretarial audit flags non-compliance in statutory auditor appointment process
*this image is generated using AI for illustrative purposes only.
Panjon has scheduled its 43rd Annual General Meeting (AGM) for Wednesday, September 30, 2026, at 12:00 pm via Video Conferencing. The meeting will transact ordinary business, including the adoption of audited financial statements for FY26 and the re-appointment of Executive Director Mrs. Anju Kothari.
The pharmaceutical and consumer products manufacturer reported revenue of ₹476.2 crore for FY26, marking a 56.35% increase from ₹304.6 crore in the previous year. Net profit rose 20.23% to ₹47.6 crore, driven by operational growth and tax adjustments.
Financial Performance
The company's top-line expansion was supported by higher sales volumes and increased purchases of finished goods. While other income dipped slightly by 2.33%, the overall profitability improved significantly.
| Metric | FY26 (₹ in hundred) | FY25 (₹ in hundred) | Change |
|---|---|---|---|
| Revenue from Operations | 47,62,061.43 | 30,45,801.47 | +56.35% |
| Total Income | 47,92,128.22 | 30,76,587.86 | +55.76% |
| Profit Before Tax | 72,445.43 | 52,744.22 | +37.35% |
| Net Profit | 47,639.88 | 39,622.89 | +20.23% |
Total expenditure rose to ₹471.9 crore from ₹302.4 crore, reflecting the scale-up in operations. Finance costs increased to ₹27.1 crore from ₹17.1 crore, while employee benefit expenses grew to ₹89.1 crore.
What the Numbers Show
Revenue growth significantly outpaced the rise in total expenditure, leading to an expansion in Profit Before Tax (PBT). PBT grew by 37.35%, whereas Net Profit grew by 20.23%. This divergence is primarily due to a reduction in total tax expenses, which turned negative (a benefit) of ₹24.8 crore in FY26 compared to ₹13.2 crore in FY25, largely driven by deferred tax assets.
Corporate Governance and Board Changes
The AGM agenda includes the regularization of Mr. Archit Kothari as a Non-Executive Non-Independent Director. He was appointed as an Additional Director on August 13, 2026, and seeks shareholder approval to continue his tenure. Key governance disclosures include:
- Auditor Appointment Non-Compliance: The Secretarial Audit Report noted that the Board appointed M/s Goyal Parul & Co. as Statutory Auditors without shareholder approval, deviating from the resolution passed at the 41st AGM which had re-appointed M/s Giriraj & Lohiya.
- Related Party Transactions: Significant transactions were recorded with Sanitex Chemical Limited, where Mrs. Anju Kothari serves as a director. Sales to the entity amounted to ₹4.8 crore, while purchases stood at ₹84.7 lakh.
- Dividend: No dividend was recommended for the year due to working capital requirements.
Meeting Details
Shareholders holding shares as of the cut-off date, Wednesday, September 23, 2026, are eligible to vote. Remote e-voting will be open from Sunday, September 27, 2026, at 9:00 am to Tuesday, September 29, 2026, at 5:00 pm.
Historical Stock Returns for Panjon
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.93% | +9.22% | +26.48% | -10.04% | +14.75% | 0.0% |
How might the non-compliance regarding auditor appointment impact Panjon's regulatory standing and investor confidence in future governance reviews?
Will the decision to withhold dividends to fund working capital requirements signal a period of aggressive expansion or potential liquidity constraints for FY27?
To what extent will the increased reliance on Sanitex Chemical Limited for related-party transactions affect Panjon's supply chain independence and margin stability?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
